News

The study will evaluate the potential of Panzem in patients who have failed treatment with Sutent (sunitinib), as well as patients who are currently being treated with sunitinib,

Both Boston Scientific and Johnson & Johnson have been asked to provide information regarding drug-eluting stents, which are tubes that keep arteries open after they have been unclogged.

The Food and Drug Administration issued the approval for Tekturna as the first in a new class of drugs called direct renin inhibitors. A once-daily oral therapy, Tekturna

Peramivir is a member of the class of antiviral agents that inhibit influenza viral neuraminidase, an enzyme that is essential for the spread of influenza virus within the

According to YM, unlike fixed dose approaches to opioid delivery, where a significant titration period is often required to determine the suitable dose for the patient, AeroLEF is

Although an independent data monitoring committee found that among the 826 patients, there was not a statistically significant difference between treatment groups in overall mortality. The phase III

Kathleen Hermans Messerschmidt, who filed suit on behalf of her brother, Brian Hermans, will not be able to continue the case against Merck into the second phase of

The agreement, following US Federal Trade Commission review, resolves litigation between Teva’s supplier of the 300 mg product, Impax Laboratories, and Biovail, involving a patent which expires in

The transaction has received approval from Hypnion stockholders and is expected to close near the end of the first quarter of 2007, subject to regulatory clearance. Financial terms